iOrganBio

iOrganBio

Pre-clinical
Boston, United StatesFounded 2021iorgan.bio

Develops bioengineered organ replacements using 3D bioprinting and stem cell technologies.

Market Cap
Private
Pipeline
Patents
Publications

Private Company

Funding information not available

About

Develops bioengineered organ replacements using 3D bioprinting and stem cell technologies.

Regenerative MedicineSynthetic Biology